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Background: The trisaccharide 20-fucosyllactose (20-FL) is one of the most abundant oligosaccharides found in
human milk. Due to its prebiotic and anti-infective properties, 20-FL is discussed as nutritional additive for infant
formula. Besides chemical synthesis and extraction from human milk, 20-FL can be produced enzymatically in vitro
and in vivo. The most promising approach for a large-scale formation of 20-FL is the whole cell biosynthesis in
Escherichia coli by intracellular synthesis of GDP-L-fucose and subsequent fucosylation of lactose with an
appropriate α1,2-fucosyltransferase. Even though whole cell approaches have been demonstrated for the synthesis
of 20-FL, further improvements of the engineered E. coli host are required to increase product yields. Furthermore,
an antibiotic-free method of whole cell synthesis of 20-FL is desirable to simplify product purification and to avoid
traces of antibiotics in a product with nutritional purpose.
Results: Here we report the construction of the first selection marker-free E. coli strain that produces 20-FL from
lactose and glycerol. To construct this strain, recombinant genes of the de novo synthesis pathway for GDP-L-fucose
as well as the gene for the H. pylori fucosyltransferase futC were integrated into the chromosome of E. coli JM109
by using the λ-Red recombineering technique. Strains carrying additional copies of the futC gene and/or the gene
fkp (from Bacteroides fragilis) for an additional salvage pathway for GDP-L-fucose production were used and shown
to further improve production of 20-FL in shake flask experiments. An increase of the intracellular GDP-L-fucose
concentration by expression of fkp gene as well as an additional copy of the futC gene lead to an enhanced
formation of 20-FL. Using an improved production strain, feasibility of large scale 20-FL production was
demonstrated in an antibiotic-free fed-batch fermentation (13 l) with a final 20-FL concentration of 20.28 ± 0.83 g l-1
and a space-time-yield of 0.57 g l-1 h-1.
Conclusions: By chromosomal integration of recombinant genes, altering the copy number of these genes and
analysis of 20-FL and intracellular GDP-L-fucose levels, we were able to construct and improve the first selection
marker-free E. coli strain which is capable to produce 20-FL without the use of expression plasmids. Analysis of
intracellular GDP-L-fucose levels identified the de novo synthesis pathway of GDP-L-fucose as one bottleneck in
20-FL production. In antibiotic-free fed-batch fermentation with an improved strain, scale-up of 20-FL could be
demonstrated.
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Figure 1 Metabolic pathways for the whole cell biosynthesis of
2′-fucosyllactose (2′-FL) in Escherichia coli. Salvage GDP-L-fucose
pathway enzyme is depicted in red, de novo GDP-L-fucose synthesis
pathway enzymes in blue and α1,2-fucosyltransferase enzyme in
green. Enzymes and molecules are abbreviated as follows: Gal,
D-galactose; GDP-4k-6d-Man, GDP-4-keto-6-deoxymannose; GDP-Man,
GDP-α-D-mannose; GDP-L-Fuc, GDP-β-L-fucose; Glc, D-glucose; FucP,
fucose permease; GlpF, glycerol MIP channel; LacY, lactose
permease; Man-1P, α-D-mannose-1-phosphate; Man-6P,
α-D-mannose-6-phosphate; ManB, phosphomannomutase; ManC,
mannose-1-phosphate guanylyltransferase; Gmd, GDP-mannose
4,6-dehydratase; WcaG, GDP-fucose synthase; FutC, α1,
2-fucosyltransferase; LacZ, β-galactosidase.
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With approximately 5 to 15 g l-1, human milk oligosac-
charides (HMOs) are the third most abundant solid
component of human milk after lactose and lipids [1].
All HMOs consist of a core structure containing at least
lactose at the reducing end and can be extended with N-
acetyllactosamine (LacNAc) units (type I or II) in a lin-
ear or branched form. The structural diversity of HMOs
is further expanded by the extensive addition of L-fucose
and/or sialic acid residues to terminal positions resulting
in over 200 different compounds identified so far [2,3].
The concentrations of different HMOs and their total
amount in human milk vary within the lactation phase
and between individuals, which is believed to be partially
based on genetic background [4,5]. Importantly, how-
ever, HMOs are not found in comparable abundances in
other natural sources, like cow, sheep, or goat milk [6].
Several beneficial effects of HMOs on infants have been
shown or suggested, including selective enhancement of
bifidobacterial growth, anti-adhesive effects on patho-
gens and glycome-altering effects on intestinal epithelial
cells [7-10]. Moreover, infants’ nutrition containing 20-
fucosyllactose (20-FL) is associated with lower rates of
diarrhea, making 20-FL a potential nutritional supple-
ment and therapeutic agent, if it were available in suffi-
cient amounts and at a reasonable price [11].
Formerly, 20-FL has been obtained via extraction from
human milk or chemical synthesis [12,13], but the lim-
ited availability of human milk or the necessity of side
group protection and deprotection in chemical synthesis,
respectively, set limits to supply and cost efficiency.
Thus, alternative sources of 20-FL became of interest.
With the identification and functional heterologous ex-
pression of an α1,2-fucosyltransferase (FutC) from
Helicobacter pylori, which can utilize lactose as acceptor
substrate [14], the research for a biotechnological alter-
native of 20-FL production was enhanced.
FutC from H. pylori and the recently characterized
WbsJ from E. coli O128:B12 are regio- and stereoselective
α1,2-fucosyltransferases which connect the fucosyl-group
in α-linkage to the 2-position of the galactosyl-residue
of saccharides such as N-acetyllactosamine or lactose
[15,16].
To obtain GDP-L-fucose for an in vivo synthesis of 20-
FL in Escherichia coli, the salvage pathway and/or the de
novo synthesis pathway can be employed (Figure 1). The
salvage pathway, catalyzed by the bifunctional enzyme
Fkp with L-fucose kinase and L-fucose-1-phosphate
guanylyltransferase activity, initially was believed to be
present only in eukaryotes but today it also known from
Bacteroides fragilis [17]. Fkp uses GTP, ATP, and L-
fucose as substrates. Utility of the salvage pathway for
GDP-L-fucose production has been demonstrated by
complementation of E. coli cells with a disrupted GDP-L-fucose de novo synthesis pathway [18]. The de novo syn-
thesis pathway, found in bacteria, mammals, and plants,
transforms mannose-6-phosphate via mannose-1-phos-
phate, GDP-mannose, and GDP-4-keto-6-deoxymannose
to GDP-L-fucose. Recombinant expression of the de novo
pathway biosynthesis genes has been used for the in vitro
and in vivo synthesis of GDP-L-fucose [19-22].
An enzymatic in vitro fucosylation of lactose to 20-FL
was accomplished by the use of recombinant α1,2-
fucosyltransferase (FutC) from H. pylori and enzymatically
prepared GDP-L-fucose [14]. But in particular the efforts
and expenses for the preparation of GDP-L-fucose make
this approach inapplicable for a large-scale production
of 20-FL. A large-scale biotransformation system for
fucosylated sugars depending on a mixture of perme-
abilized Corynebacterium ammoniagenes and different
E. coli cells was demonstrated by Koizumi et al. [23]. In
this system, C. ammoniagenes was utilized for GTP regen-
eration, whereas different E. coli strains, expressing genes
for GDP-L-fucose biosynthesis and fucosyltransferase,
were used for the production of GDP-L-fucose and
fucosylated oligosaccharides.
Whole cell biosynthesis of 20-FL was carried out
employing E. coli strains that provide endogenous GDP-
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tain sufficient amounts of GDP-L-fucose for cytoplasmic
fucosylation reactions, different strategies were followed.
It has been shown that GDP-L-fucose formation can be
achieved by overexpression of plasmid-borne genes
(manB, manC, gmd, wcaG) of the GDP-L-fucose de novo
pathway [24,25]. In another approach, Dumon et al. [26]
used plasmids to overexpress the gene for the positive
regulator protein of the colanic acid biosynthesis, RcsA
in an E. coli strain with inactivated wcaJ gene encoding
the UDP-glucose lipid carrier transferase. This resulted
in synthesis of GDP-L-fucose but avoided the formation
of colanic acid.
So far, all approaches for the whole-cell synthesis of
fucosylated oligosaccharides relied on the expression of
plasmid-borne genes to obtain the necessary proteins. Ex-
pression plasmids are expedient for cloning and short-term
expression of recombinant genes, in particular for the max-
imum overproduction of a given protein. For the in vivo
synthesis of a natural product in a bacterial host, where
multiple genes have to be expressed, the use of expression
plasmids has several disadvantages. Plasmids tend to struc-
tural and segregational instability, that can lead to the loss
or inactivation of the genes to be expressed [27]. To main-
tain expression plasmids in the cell, selection markers, like
antibiotic resistance genes or plasmid addiction systems,
are required. Such selection systems lead to the loss of via-
bility of plasmid-free cells, but cannot avoid segregational
instability. Moreover the metabolic burden of plasmid rep-
lication and the strong overexpression of certain genes can
lead to reduced growth rates and increased demand of en-
ergy and metabolites for the additional pathway [28]. Most
importantly, in processes aimed for human nutrition, the
use of antibiotics is either legally forbidden or undesired
for cost reasons. In addition, removal of antibiotics in
downstream processing is elaborate and expensive.
To avoid these disadvantages, stable insertion of re-
combinant genes into the chromosome of the bacterial
host may be desired. The chromosomal integration al-
lows the maintenance of recombinant genes without the
use of selection marker. For Escherichia coli, several
methods have been developed for the insertion of ex-
pression cassettes into chromosome and its use for the
synthesis of value products [29-33].
In the present study, we have constructed an E. coli
strain carrying individual expression cassettes of genes
on the chromosome to allow synthesis of GDP-L-fucose
or 20FL. Using this strain as platform, experiments were
carried out to identify possible bottlenecks in GDP-L-
fucose supply and fucosylation activity. After chromo-
somal integration of an additional copy of the
fucosyltransferase gene, fed-batch fermentation was
conducted to obtain higher yields of 20-FL on a 13 liter
scale in an antibiotic-free process.Results
Construction of 20-FL producing Escherichia coli strains
To realize the whole-cell synthesis of 20-fucosyllactose,
E. coli JM109 was chosen as parent strain. E. coli JM109
is a β-galactosidase-negative but lactose permease posi-
tive strain. This feature allows lactose uptake while its
further metabolism is blocked. To allow the intracellular
synthesis of GDP-L-fucose, genes of the GDP-L-fucose
de novo pathway were cloned and integrated into the
chromosome as individual expression cassettes under
the control of an IPTG-inducible Ptac-promoter. For this
purpose the reading frames of manB, manC, and gmd-
wcaG were cloned into the expression vector pJF119ΔN,
respectively. The resulting plasmids (pJF-manB, pJF-
manC, pJF-gmdwcaG (Table 1)) were each equipped
with a FRT-flanked antibiotic resistance gene (cat or
kan) downstream of the biosynthesis gene. From the
gained plasmids the expression cassettes, including a
Ptac-promoter, a proper Shine-Dalgarno sequence follo-
wed by the individual biosynthesis gene, a FRT-cat-FRT
or FRT-kan-FRT resistance marker, and a transcription
terminator sequence (from rrnB) were each amplified by
PCR. The PCR primers (Additional file 1: Table S1) were
chosen in a way that each PCR product of the individual
expression cassettes is flanked on both sides by a 50–60
bp DNA sequence which is homologous to the indi-
vidual target sequence on the chromosome of E. coli
JM109. The PCR products were inserted successively
into different sugar degradation loci on the chromosome
as described previously [32]. After each round of expres-
sion cassette integration, the antibiotic resistance gene
was removed by the transient expression of a Flp
recombinase [34], resulting in the strain E. coli JM109
gwBC (Table 1). To verify the synthesis of GDP-L-
fucose by JM109 gwBC, the strain was equipped with a
gene for the α1, 2-fucosyltransferase from H. pylori via
the expression vector pJF-futC. Production of 20-FL
could be detected in the culture after IPTG induction
and addition of lactose (data not shown). No 20-FL was
seen in control experiments using E. coli JM109 pJF-
futC.
Based on strain JM109 gwBC, futC was integrated in
the same way as described above, into the maltose locus
malEFG, resulting in the strain JM109 gwBC-F1 (Figure 2).
Shake flask cultivation of this strain, comprising the
basic configuration of the required biosynthesis genes,
revealed its ability to synthesize 20-FL after IPTG in-
duction and addition of lactose. In order to investigate
rate limiting steps in the formation of 20-FL by E. coli
JM109 gwBC-F1 in whole cell biotransformation, con-
cerning GDP-L-fucose supply or fucosylation reaction,
the strain was further equipped with the GDP-L-fucose
salvage pathway (fkp) and an additional copy of the
fucosyltransferase gene (futC), resulting in the E. coli
Table 1 Bacterial strains and plasmids used in this study
Strains Relevant genotype or sequences Source or reference
E. coli DH5α F-, ϕ80d, lacZΔM15, endA1, recA1, hsdR17(rK
-mK
- ),
supE44, thi-1, gyrA96, relA1, Δ(lacZYA-argF)U169
laboratory strain
E. coli JM109 F′ traD36 proA+B+ lacIq Δ(lacZ)M15/Δ(lac-proAB)
glnV44 e14- gyrA96 recA1 relA1 endA1 thi hsdR17
laboratory strain
E. coli JM109 gwBC E. coli JM109, rbsDK::manC,
melAB::manB, xylAB::gmdwcaG
this study
E. coli JM109 gwBC-F1 E. coli JM109, rbsDK::manC, melAB::manB,
xylAB::gmdwcaG, malEG::futC
this study
E. coli JM109 gwBC-F1-fkp E. coli JM109, rbsDK::manC, melAB::manB,
xylAB::gmdwcaG, malEG::futC, fucIK ::fkp
this study
E. coli JM109 gwBC-F2 E. coli JM109, rbsDK::manC, melAB::manB,
xylAB::gmdwcaG, malEG::futC, fucIK ::futC
this study





pKD46 ParaB γ β exo (red recombinase), AmpR [35]
pCP20 FLP+, λ cI857+, λ pR Repts, AmpR, CmR [34]
pMJC54 pET16b, B. fragilis fkp gene, AmpR [17]
pCAW48 pET11a, S. enterica manB gene, AmpR Albermann & Piepersberg
(unpublished)
pCAW49 pET11a, S. enterica manC gene, AmpR Albermann & Piepersberg
(unpublished)
pCAW55 pJOE2775, H. pylori futC gene, AmpR [14]
pCAS30-FRT-cat-FRT pJF119ΔN, P. ananatis crtE gene, FRT-sites, AmpR, CmR [36]
pJF-crtY-FRT-kan-FRT pJF119ΔN, P. ananatis crtY gene, FRT-sites, AmpR, KanR [32]
pQE31-FRT-cat-FRT pQE31, FRT-sites, AmpR, CmR [37]
pJF119ΔN cloning vector, RBS, Ptac, Amp
R [38]
pJF-manB pJF119ΔN, S. enterica manB gene, AmpR this study
pJF-manC pJF119ΔN, S. enterica manC gene, AmpR this study
pJF-gmdwcaG pJF119ΔN, E. coli gmd, wcaG gene, AmpR this study
pJF-futC pJF119ΔN, H. pylori futC gene, AmpR this study
pJF-fkp pJF119ΔN, B. fragilis fkp gene, AmpR this study
pJF-manB-FRT-cat-FRT pJF119ΔN, S. enterica manB gene, FRT-sites, AmpR, CmR this study
pJF-manC-FRT-kan-FRT pJF119ΔN, S. enterica manC gene, FRT-sites, AmpR, KanR this study
pJF-gmdwcaG-FRT-cat-FRT pJF119ΔN, E. coli gmd, wcaG gene, FRT-sites, AmpR, CmR this study
pJF-futC-FRT-cat-FRT pJF119ΔN, H. pylori futC gene, FRT-sites, AmpR, CmR this study
pJF-fkp-FRT-cat-FRT pJF119ΔN, B. fragilis fkp gene, FRT-sites, AmpR, CmR this study
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JM109 gwBC-F2-fkp (Figure 2). By knocking-out the
genes for fucose-isomerase (fucI) and fuculose-kinase
(fucK) via insertion of fkp or the second copy futC, the
strains lose the ability to degrade intracellular L-fucose.
Determination of intracellular GDP-L-fucose levels and 20-
fucosyllactose formation
To analyze the relation of GDP-L-fucose availability and
20-FL production, intracellular GDP-L-fucose levels andcell dry weight concentrations (CDW) of the construc-
ted 20-FL producing strains were determined. The
strains were cultivated in glycerol minimal medium,
supplemented with 0.2% L-fucose. Whereas GDP-L-
fucose was not detectable in the control strain JM109,
intracellular accumulation was found in strains with the
de novo pathway and about 10 times more GDP-L-
fucose (about 5 mg gCDW
-1 ) was found, when the fkp gene
was present (Figures 3 and 4). GDP-L-fucose levels mea-
sured 4 hours after induction showed equal levels of
Figure 2 Genetic modifications in E. coli strains compared in this study. Chromosomally integrated genes in arrows, knocked-out sugar
degradation genes and chromosomal position of knock-out by knock-in area in kb are given below corresponding integrated gene.
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values 12 hours after induction.
To determine the 20-FL formation, shake flask cultiva-
tions were performed with glycerol minimal medium,
supplemented with 0.2% lactose and, in strains carrying
the fkp gene, 0.2% L-fucose. The experiments revealed
that the strains that carry fkp show a significantly higher
formation of 20-FL and a significantly higher 20-FL yield
from lactose, than strains expressing the de novo path-
way only (Figure 5A and C). The highest formation of
20-FL was observed by E. coli JM109 gwBC-F2-fkp
(387.76 ± 6.71 mg2’-FL gCDW


















Figure 3 HPLC analysis of intracellularly accumulated GDP-L-fucose. A
extract of E. coli JM109 gwBC-F1 12h after induction. C) Cell extract of E. co
fucose and GDP, respectively.which relies on the de novo pathway only, produced
about 30% less 20-FL. That is, however, 15% higher than
the production by the basic strain JM109 gwBC-F1 with
only one futC copy on the chromosome. This shows that
a higher intracellular GDP-L-fucose concentration as
well as the additional futC expression cassette is benefi-
cial to the increased formation of 20-FL compared to the
basic strain E. coli JM109 gwBC-F1. From cell dry
weight determinations (after shake flask cultivations;
Figure 5B) it became apparent that the biomass yield of
strains that carry fkp, and thereby produce GDP-L-






) Cell extract of E. coli JM109 gwBC-F1-fkp 12h after induction. B) Cell
li JM109 12h after induction. Arrows indicate retention time of GDP-L-
Figure 4 Intracellular concentrations of GDP-L-fucose in E. coli
strains with or without salvage synthesis pathway for GDP-L-
fucose 12 hours after induction.
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L-fucose formation. We take this for evidence that the
subtraction of fructose-6-phosphate and NADPH by the
de novo pathway reduces the carbon and energy pool of
the cell and thus diminished the biomass yield. Strains
with the additional salvage pathway, in contrast, use the
fed L-fucose for GDP-L-fucose synthesis. Comparing ra-
tios of carbon atoms found in glycerol or in glycerol and
L-fucose with carbon atoms found in the fucosyl-residue
of the produced 20-FL, strains with the salvage synthesis
pathway of GDP-L-fucose demonstrate significantly
higher rates. The strain JM109 gwBC-F2-fkp shows 6.15 ±
0.13% of supplemented carbon atoms (without lactose)
transferred to the fucosyl-residue of produced 20-FL, while
the strain JM109 gwBC-F2 without salvage synthesis
pathway for GDP-L-fucose only shows 3.68 ± 0.24%
(Figure 5D).
Genetic stability of the E. coli strain JM109 gwBC-F2
was analyzed under the assumption, that loss or muta-
tion of the chromosomally integrated cassettes would re-
sult in shifts of the 20-FL production rates or in the
complete abolition of 20-FL formation. For this, the
strain JM109 gwBC-F2 was cultivated in minimal
medium for several days with transfer to shake flask with
new medium each 24 hours until it reached over 100
generations. When comparing 20-FL yields in minimal
medium with 0.2% lactose 24 hours after induction, cul-
tures that had been cultivated for more than 100 genera-
tions still showed 95.01 ± 1.88% of the 20-FL yield,
observed in reference cultivations.
Production of 20-FL by fed-batch cultivation
In order to demonstrate a large scale synthesis of 20-FL
by a recombinant E. coli strain without expressionplasmids and the use of any selection marker, the strain
E. coli JM109 gwBC-F2 was used in a 13.5 liter fed-batch
cultivation (Figure 6). Glycerol was used as carbon- and
energy-source, whereas lactose was used as substrate for
fucosylation only. After glycerol consumption in the
batch phase the culture was induced with IPTG and lac-
tose, glycerol, and nutrient feeding were started. After
35.5 hours, a total 20-FL concentration of 20.28 ± 0.83
g l-1 was produced by a final cell dry weight concentra-
tion of 65.61 g l-1. This equals a 20-FL yield of 309.16 ±
12.61 mg gCDW
-1 , being in the same order of magnitude
as the yield measured in the shake flask experiments.
The space-time-yield of the 20-FL formation over the
whole process was 0.57 g l-1 h-1. Analysis of the culture
broth showed an almost equal distribution of 20-FL in
the culture broth and in the cell pellet with 10.22 ± 0.38
g lculture
-1 and 10.18 ± 1.71 g lculture
-1 , respectively. The final
glycerol concentration of the fed-batch culture was
below the detection limit and the final acetate concen-
tration was 0.262 ± 0.002 g lculture
-1 . To confirm the
synthesis of 20-FL by E. coli JM109 gwBC-F2, the oligo-
saccharide product was isolated from 50 ml culture by
activated charcoal and size-exclusion chromatography.
The isolated oligosaccharide (400 mg) was analyzed by
MS and NMR (Additional file 2: Figure S1) and results
were in agreement with previously reported assignments
of 20-FL [14].
Discussion
Oligosaccharides found in human milk have been shown
to be beneficial for the infants’ health. HMOs have been
reported to serve as selective growth factor for specific
bacteria such as Lactobacilli or Bifidobacteria [39] and
they function as anti-adhesive antimicrobials that inhibit
the adhesion of pathogenic viruses or bacteria to epithe-
lial cells [40]. Furthermore, small quantities of HMOs
may also be absorbed into the gastrointestinal tract
where they modulate epithelial and immune cell re-
sponse [41].
It was shown by in vitro and in vivo studies that 20-FL
has an anti-adhesive effect against Campylobacter jejuni
and thereby lowers the risk of bacterial diarrhea caused
by this organism [11,42]. In addition, 20-FL selectively
promotes the growth of bifidobacteria [43]. Due to these
important biological activities of HMOs, efficient ways
for HMO synthesis are needed. Currently, both chemical
and enzymatic approaches are used for the formation of
20-FL [13,14,25,44,45]. Especially the enzymatic forma-
tion of 20-FL using a recombinant in vivo biosynthesis
approach is to the best advantage, because co-factors
like NADPH and GTP, needed for the enzymatic synthe-
sis of GDP-L-fucose, can be regenerated in situ by the
metabolism of the cell. For the in vivo production of 20-
FL by E. coli the expression of a GDP-L-fucose
Figure 5 Comparison of modified E. coli strains in shake flask experiments. A) 2′-FL yield of batch cultivated strains with or without salvage
GDP-L-fucose production 24 hours after induction. B) Cell dry weight concentrations corresponding to Figure 5A. C) Produced 2′-FL from lactose
corresponding to Figure 5A. D) Percentage of carbon atoms converted from glycerol or glycerol and L-fucose to the fucosyl-residue of the
produced 2′-FL corresponding to Figure 5A.
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are prerequisites. In previous studies, the intracellular
formation of GDP-L-fucose in E. coli was achieved by
the expression of the de novo biosynthesis genes manB,
manC, gmd, and wcaG or by the RcsA-mediated activa-
tion of the native de novo pathway [24,26,46]. The α1,2-
transfer of the L-fucosyl group from GDP-L-fucose to
lactose can be achieved by the heterologous expression
of the promiscuous α1,2-fucosyltransferase FutC from
H. pylori [14,45,47].
So far, plasmids have been used for the expression of a
heterologous 20-FL biosynthesis pathway in E. coli
strains, but the use of expression plasmids, in particular
for large scale bioreactor cultivation, has several disad-
vantages. Plasmids tend to structural and segregationalinstability and therefore require a selection marker, like
an antibiotic resistance gene, to maintain propagation of
the plasmid in the cell [27]. For applications in food in-
dustry, especially the addition of antibiotics is undesir-
able. Furthermore the imbalanced expression of a few
biosynthesis genes, either by high copy plasmids and/or
strong promoters, can cause a metabolic burden effect
and, thus, may lower product and/or biomass yield
[28,48]. In the present study, to avoid the negative ef-
fects caused by plasmid-based expression, the required
biosynthesis genes were integrated into the chromosome
of E. coli as previously described [32]. Thus, up to six
individual expression cassettes were established in
the chromosome by replacing dispensable sugar degra-
dation genes. Concerning the stability of the inserted
Figure 6 2′-FL production in 10 liter scale glycerol-limited fed-
batch fermentation of E. coli JM109 gwBC-F2. Glycerol-, nitrogen-
and lactose-feeds started with induction, marked by a turquoise
vertical line. The glycerol and nutrient feed rates were adjusted to
maintain a growth rate of μ = 0.1 h-1. Lactose feed rate was
manually adjusted as described in the methods section. To allow a
complete conversion of lactose into 2′-FL, the lactose feeding was
stopped after a total process time of 30 hours. Symbols denote as
follows: black circles, cell dry weight concentration; red triangles,
concentration of 2′-fucosyllactose; blue circles, concentration
of lactose.
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somal DNA is subject to evolutionary modifications by
recombination or point mutation, but so far we have no
evidence that the integrated expression cassettes tend to
higher structural instability.
In contrast to previous works that used E. coli JM109
(DE3) as host for 20-FL production [25,45], E. coli
JM109, which has no detectable β-galactosidase activity,
was employed to ensure the complete conversion of the
lactose, assimilated via LacY, to 20-FL (Figure 1). With
the construction of the strain JM109 gwBC-F1, and the
subsequent shake flask cultivations, we created an ex-
pression plasmid-free E. coli strain producing 206.16 mg
gCDW
-1 20-FL from lactose in minimal medium shake flask
cultivation with glycerol as carbon source (Figure 5A).
To improve 20-FL productivity, strain development was
used to identify possible bottlenecks in the in vivo
fucosylation pathway. For the enzymatic formation of
GDP-L-fucose the de novo synthetic and the salvage syn-
thetic pathways have been described [17,19,20]. Here, in
addition to the recombinant GDP-L-fucose de novo
pathway, the salvage pathway was established in E. coli
in order to modulate the intracellular GDP-L-fucose
concentration. The salvage pathway requires the supply
of L-fucose to the medium, from where the uptake is
mediated by FucP. The intracellular degradation of L-
fucose was prevented by the knock-out of fucI and fucK
via the insertion of an expression cassette into fucIK(Figure 2). The additional GDP-L-fucose salvage pathway
in a strain expressing the de novo pathway yielded an
about 10 times higher intracellular concentration of the
activated 6-deoxyhexose up to 5.1 mg gCDW
-1. In a strain
using only the de novo pathway, the lower GDP-L-
fucose content maybe contributed to the feed-back
inhibition of GDP-mannose-4,6-dehydratase by GDP-L-
fucose [20,49,50]. Studies by Lee et al. [46,51] showed
that the GDP-L-fucose content in the cell can be in-
creased by the high expression of manB, manC, gmd,
and wcaG as well as by the higher availability of NADPH
in the cell with concentrations up to 2.8 mg gCDW
-1.
Comparison of E. coli JM109 gwBC-F1 with E. coli
JM109 gwBC-fkp-F1 showed an increase in 20-FL prod-
uctivity of over 80% with the salvage pathway of GDP-L-
fucose synthesis indicating a bottleneck in the GDP-L-
fucose supply for the fucosylation reaction in JM109
gwBC-F1 (Figure 5A). It should also be noted that the
biomass yield of strains using the salvage pathway is sig-
nificantly increased, reflecting a probable metabolite sav-
ing as the fucose-residue of 20-FL mainly does not need
to be withdrawn from anabolism, but is added with the
fed fucose.
An increase in productivity of about 25% was observed
with E. coli JM109 gwBC-F2 carrying an additional futC
expression cassette on the chromosome compared to E.
coli JM109 gwBC-F1. However, only a marginal increase
in 20-FL yield was seen by cultivations of E. coli JM109
gwBC-fkp-F2 compared to E. coli JM109 gwBC-fkp-F1.
Thereby it can be concluded that, for the here reported
basic 20-FL producing strain E. coli JM109 gwBC-F1,
both the expression of the fucosyltransferase as well as
the supply of GDP-L-fucose represent rate limiting fac-
tors towards the in vivo synthesis of 20-FL. Whereas the
supply of GDP-L-fucose, that could be increased by the
use of the salvage pathway, had the strongest effect on
the in vivo 20-FL formation.
In order to demonstrate an upscale of the 20-FL syn-
thesis using an expression plasmid-free production
strain, a fed-batch cultivation of E. coli JM109 gwBC-F2
with glycerol as C- and energy source and lactose as
substrate was conducted. Focusing on the production of
high concentrations of 20-FL combined with small
amounts of remaining lactose to simplify the product
purification process, a final product concentration of
20.28 ± 0.83 g l-1 could be achieved in a total process
time of about 35.5 hours. With a final culture volume of
13.5 liters, a total amount of 273 g 20-fucosyllactose and
a space time yield of about 0.57 g l-1 h-1 were reached.
Compared to a fed-batch cultivation using E. coli with
two expression plasmids described by Drouillard et al.
[45], an increase in final concentration of almost 45%
and an increase in productivity of about 83% were ob-
served. This shows that an efficient in vivo fucosylation
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combinant 20-FL biosynthesis genes. Our study empha-
sizes the need for balanced activities of biosynthesis
enzymes for an efficient whole cell synthesis approach.
A further improvement of the 20-FL formation via the de
novo pathway might be feasible by increasing the carbon
flux towards GDP-L-fucose.
Conclusions
In this study we constructed and improved an expres-
sion plasmid-free E. coli strain capable of the whole cell
biosynthesis of the human milk oligosaccharide 20-
fucosyllactose from lactose and glycerol. The recombin-
ant genes needed for the expression of a fucosyllactose
biosynthesis pathway were integrated into the chromo-
some of E. coli JM109 as individual expression cassettes.
By comparing strains expressing the GDP-L-fucose de
novo- and the salvage-pathway, strains with one or two
copies of the fucosyltransferase gene, and by measuring
intracellular levels of GDP-L-fucose, we could identify
bottlenecks in the 20-FL biosynthesis for our production
system. By a large-scale fed-batch cultivation we could
demonstrate the efficient whole cell synthesis of 20-
fucosyllactose using a plasmid-free production strain
without the use of antibiotics as selection markers.
Methods
Bacterial strains, media, and chemicals
All strains constructed are based on the lacZ-negative,
but lacY-positive laboratory strain E. coli JM109 (Table 1
and Figure 2). If not stated otherwise, E. coli strains were
grown at 37°C in LB medium. The minimal medium
used for shake flask cultivation had the following com-
position: KH2PO4 3 g l
-1, K2HPO4 12 g l
-1, (NH4)2SO4 5
g l-1, MgSO4 · 7H2O 0.3 g l
-1, CaCl2 · 2H2O 0.015 g l
-1,
NaCl 0.1 g l-1, glycerol 10 g l-1, FeSO4 · 7H2O/sodium
citrate 15 ml l-1 (from the solution of 7.5 g l-1 FeSO4 ·
7H2O and 100 g l
-1 sodium citrate), thiamine 7.5 μg l-1,
trace element solution 33 ml l-1 [52]. Antibiotics for strain
constructions were used at the following final concentra-
tions: ampicillin 100 μg ml-1, kanamycin 50 μg ml-1, chlor-
amphenicol 50 μg ml-1. Difco MacConkey agar base was
purchased from Nordwald (Germany). 20-fucosyllactose
standard was purchased from IsoSep (Sweden); GDP-L-
fucose was from Jennewein Biotechnologie (Germany). All
other chemicals and reagents were from Sigma-Aldrich or
Roth (Germany) and were of the highest purity available.
Construction of plasmids
All used and constructed plasmids are listed in Table 1.
The reading frames of manB, manC, gmd/wcaG, and fkp
were individually cloned into the NdeI and BamHI sites
of the expression vector pJF119ΔN [38], respectively.
manB was subcloned from plasmid pCAW48 to yieldpJF-manB. The gene manC was subcloned from plasmid
pCAW49 to yield pJF-manC. A PCR product containing
the reading frames of gmd and wcaG, as previously de-
scribed [20], was digested with NdeI and BglII enzymes
and ligated to vector pJF119ΔN DNA which had been
digested with NdeI plus BamHI. This yielded plasmid
pJF-gmdwcaG. The gene fkp was subcloned from plas-
mid pMJC54 to yield pJF-fkp. The reading frame of the
fucosyltransferase gene futC was subcloned from plas-
mid pCAW55 into pJF119ΔN using NdeI and PstI re-
striction sites. The plasmid pJF-gmdwcaG was further
treated with HindIII and ligated with a HindIII digested
FRT-cat-FRT fragment derived from plasmid pCAS30-
FRT-cat-FRT and transformed into E. coli DH5α. Plas-
mids pJF-manB and pJF-futC were treated with SphI and
ligated with a SphI digested FRT-cat-FRT fragment de-
rived from plasmid pCAS30-FRT-cat-FRT, respectively.
Plasmid pJF-manC was hydrolyzed by SalI and ScaI and
ligated with a 2.4 kb SalI/ScaI fragment received from
plasmid pJF-crtY-FRT-kan-FRT containing FRT-kan-FRT
cassette. Finally, a FRT-cat-FRT SalI fragment was
subcloned from plasmid pQE31-FRT-cat-FRT into SalI
hydrolyzed pJF-fkp.Chromosomal integration of expression cassettes
The individual expression cassettes of manB, manC,
gmd-wcaG, fkp and futC including the FRT-flanked
antibiotic-resistance genes from plasmid pJF-manB-FRT-
cat-FRT, pJF-manC-FRT-kan-FRT, pJF-gmdwcaG-FRT-
cat-FRT, pJF-fkp-FRT-cat-FRT, and pJF-futC-FRT-cat-
FRT, respectively, were amplified by PCR. The
oligonucleotide primers for the amplification of the ex-
pression cassettes are listed in Additional file 1: Table S1.
For the chromosomal integration of the expression cas-
settes, the purified PCR products were consecutively
transformed into E. coli JM109 carrying plasmid pKD46.
Expression of the λ-Red enzymes and the preparation of
competent cells were carried out as described previously
[32,35]. Competent cells were electroporated with 0.2-0.4
μg of PCR product. After electroporation, the cells were
resuspended in 1 ml LB-medium and incubated at 30°C
for 12 h with shaking. Subsequently, the cell suspension
was spread onto LB-agar plates containing chloram-
phenicol or kanamycin, according to the antibiotic resist-
ance cassette in use. Antibiotic-resistant clones were
assayed on MacConkey agar plates containing 1% of the
respective sugar, corresponding to the targeted genes re-
sponsible for sugar degradation. Clones, that stayed pale
on MacConkey agar after incubation over night at 37°C,
were checked regarding correct recombination by con-
trol PCR. After each successful integration the antibiotic
resistance cassette was eliminated using the plasmid
pCP20 as previously described [34].
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To determine 20-FL productivity, strains were cultivated
in 250 ml shake flasks with 25 ml minimal medium
containing 10 g l-1 glycerol as carbon source for growth.
IPTG was added to a final concentration of 0.5 mM
when cells had reached an optical density (OD600) be-
tween 0.4 and 0.6 and lactose (2 g l-1 final concentration)
was added. Furthermore, cultures of strains expressing
fkp were supplemented with L-fucose (2 g l-1 final con-
centration) at time of induction. 4 hours and 24 hours
after induction, 10 ml culture samples were spun down
(3500 rpm, 15 min); supernatants were stored at −20°C
until HPLC analysis. Cell pellets were washed with 5 ml
of deionized water and spun down as before. Afterwards,
pellets were resuspended in 1 ml of deionized water and
disrupted by boiling (5 min, 100°C). After another cen-
trifugation (25 min at 5100 rpm), supernatants were
stored at −20°C until HPLC analysis.
Determination of 20-fucosyllactose and lactose
concentrations
Oligosaccharide concentrations in shake flask experi-
ments and fed-batch fermentation were determined by
HPLC of the 2-aminobenzoic acid-labeled saccharides.
Samples and standards of 20-FL and lactose were
derivatized with anthranilic acid in presence of sodium
cyanoborohydride [53]. HPLC analysis was performed
on Dionex HPLC Instrument (Germany), installed with
a Chromeleon Software, Gina autosampler, P580 pumps,
and a RF2000 fluorescence detector. Products were ana-
lyzed on a Luna C18 (2) reversed phase column (250
mm × 4.6 mm, 5 μm, Phenomenex, Germany). Mobile
phase consisted of solvent 1 (aqueous solution
containing tetrahydrofuran 1% (v/v), orthophosphoric
acid 0.425% (v/v) and 1-butylamine 0,3% (v/v)) and solv-
ent 2 (acetonitrile). With a flow rate of 1 ml min-1, a gra-
dient was applied with 97.5% solvent 1/2.5% solvent 2 at
beginning and 80.5% solvent 1/19.5% solvent 2 after 25
minutes followed by a 4 minute isocratic period with
80.5% solvent 1/19.5% solvent 2 and a 5 minute equili-
bration period with starting conditions. Standards and
samples were analyzed in duplicates and standard curves
were created from 6 different concentrations.
Measurement of intracellular GDP-L-fucose concentration
The E. coli strains JM109 gwBC-F1, JM109 gwBC-F1-fkp,
JM109 gwBC-F2, and JM109 gwBC-F2-fkp were cultivated
in shake flasks at 37°C in 100 ml minimal medium
containing 1% glycerol. At an OD600 of 0.4 the gene ex-
pression was induced by addition of IPTG (0.5 mM final
concentration). For cultures of E. coli JM109 gwBC-F1-fkp
and E. coli JM109 gwBC-F2-fkp, L-fucose was added to a
final concentration of 0.2% (w/v). 4 and 12 hours after in-
duction, 25 ml of the culture were harvested bycentrifugation (3500 rpm, 15 min), cells were washed with
5 ml deionized cold water, resuspended in 1 ml water and
then disrupted by boiling (100°C, 2 min). After centrifuga-
tion (14000 rpm, 20 min), the supernatant was analyzed
by HPLC. GDP-L-fucose was detected by UV-photometry
at 254 nm (Dionex HPLC Instrument (as described above)
installed with a diode array detector (Dionex, Germany)).
As mobile phase a phosphate-buffer (solvent A: 30 mM
potassium-phosphate, pH 6.0; 5 mM tetrabutylammonium
hydrogen sulfate; 2% acetonitrile) and acetonitrile (solvent
B) was used. As stationary phase, a reverse phase HPLC
column (Gemini-NX C18, 250 × 4 mm (Phenomenex,
Germany)) was used. The following flow gradient with a
flow rate of 1.5 ml min-1 was applied: 0 to 10 min linear
gradient from 100% solvent A/0% solvent B to 98% solvent
A/2% solvent B, 10 to 30 min linear gradient from 98%
solvent A/2% solvent B to 60% solvent A/40% solvent B,
30 to 30.10 min linear gradient from 60% solvent A/40%
solvent B to 100% solvent A/0% solvent B, 30.10 to 35
min isocratic conditions to equilibrate the column at
100% solvent A/0% solvent B. GDP-L-fucose was identi-
fied by co-chromatography using authentic standard com-
pound and by analysis of its UV–vis spectra. For the
quantification of GDP-L-fucose the integrated peak areas
were compared to HPLC standard curves of authentic
standards.Assessment of genetic stability of E. coli JM109 gwBC-F2
Assuming, that loss or mutation of chromosomally inte-
grated genes would lead to shifts or loss in productivity,
genetic stability of the strain E. coli JM109 gwBC-F2 was
analyzed by cultivating the strain for more than 100 gen-
erations before analyzing the 20-FL yield. To cultivate
the strain for over 100 generations, 10ml cultures of E.
coli JM109 gwBC-F2 in glycerol minimal medium were
incubated for 24 hours, before measuring OD600 and
using the culture to inoculate a fresh shake flask to
OD600 of 0.01. Passed generations were calculated by
OD600. After 100 generations, the production of 2
0-FL
was determined as described above.Fed-batch cultivation
Scale-up of 20-FL production employing E. coli JM109
gwBC-F2 was performed in a 30 l stirred-tank reactor
(Bioengineering AG, Switzerland) with a batch volume
of 8.4 l and a total feed volume of 5.1 l using mineral salt
medium modified from Wilms et al. [54] and glycerol as
carbon source. Medium used for preculture and batch
fermentation contained (NH4)2SO4 2.68 g l
-1, (NH4)2-H-
citrate 1 g l-1, glycerol 26.42 g l-1, K2HPO4 14.6 g l
-1,
MgSO4 0.241 g l
-1, Na2SO4 2 g l
-1, NaH2PO4 · H2O 4 g l
-1,
NH4Cl 0.5 g l
-1, thiamine 10 mg l-1, and trace element
solution 3 ml l-1.
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23.5 g l-1, thiamine 0.6 g l-1 and trace element solution
119 ml l-1. As nitrogen-source, (NH4)2HPO4 396 g l
-1
was deployed and for 20-FL production, a lactose solu-
tion 150 g l-1 was fed.
Trace element solution consisted of CaCl2 · 2 H2O 0.5
g l-1, FeCl3 · 6 H2O 16.7 g l
-1, Na2-EDTA 20.1 g l
-1,
ZnSO4 · 7 H2O 0.18 g l
-1, MnSO4 · H2O 0.1 g l
-1, CuSO4 ·
5 H2O 0.16 g l
-1, and CoCl2 · 6 H2O 0.18 g l
-1. Fed-batch
cultivation was operated at 37°C at a pH regulated to 7.0
using 25% (v/v) ammonium hydroxide solution. The par-
tial oxygen concentration (pO2) was maintained above
50% saturation by adjusting stirrer speed and aeration
rate. The reactor pressure was maintained 500 hPa
above surrounding pressure. 8 liters of batch medium
were inoculated with 0.4 liters over-night preculture
resulting in an OD600 of 0.22. After glycerol from batch
medium had been consumed, indicated by a rise in
dissolved oxygen, expression was induced by IPTG (0.5
mM final concentration) and feeding was started.
Glycerol- and ammonia feeds were fed in a ratio of
81:19 with a carbon-limited growth rate (μset) of 0.1 h-1
according to equation 1:
F tð Þ ¼ μset=Yx=s
  þm : cx0:V0ð Þ=cs0½ :exp μset:tð Þ
ð1Þ
with F [l h-1] being the feeding rate, μset [h-1] the de-
sired growth rate, m [g g-1 h-1] the specific maintenance
coefficient (calculated to be 0.04 g g-1 h-1), YX/S [g g
-1]
the specific yield coefficient of biomass from substrate
(estimated from shake flask experiments to be 0.29 g g-1,
data not shown), cx0 [g l
-1] the biomass concentration at
beginning of the feeding phase (7.9 g l-1), V0 [l] the
working volume of the reactor at beginning of the feed-
ing phase (8.4 l), cs0 [g l
-1] the glycerol concentration in
the feed (629.1 g l-1), and t [h] the feeding time [55].
Lactose feeding also began with induction and the flow
rate was set to 40.5% of the feeding rate calculated for
the glycerol feed for the first 10 hours after induction. It
was set to 50.6% of the glycerol feeding rate calculated
above for the next 6.5 hours and set to a fixed rate of 9.25
l h-1 for the final 6 hours of the process. These adjustments
of the lactose feeding rate were chosen to prevent lactose
limitation and extensive lactose accumulation. Lactose
feeding was stopped short before glycerol feeding to
minimize the amount of remaining lactose. Cell biomass
was determined by measuring OD600 and cell dry weight.
Determination of glycerol and acetate concentrations
Remaining glycerol and accumulated acetate were ana-
lyzed in the supernatant at the endpoint of fermentation.
Glycerol was measured using a glycerol test-kit for
foodstuffs and other materials (r-biopharm, Germany),whereas the acetate concentration was measured via
HPLC as follows. Culture supernatant was boiled for
5 minutes and centrifuged for 15 minutes at 14000 rpm.
After centrifugation, the supernatant was used for HPLC
analysis on an Agilent 1100 Series HPLC system (Agilent
Technologies, USA), equipped with ChemStation for LC
3D systems software, column heater, QuatPump, degasser,
a RI-71 refractive index detector (Showa Denko, Japan),
and an organic-acid column (300 mm× 8 mm, CS-
Chromatographie Service, Germany). The mobile phase
consisted of 5 mM sulfuric acid with a flow rate of 1 ml
min-1. Samples were analyzed in duplicates and the stand-
ard curve was created from 5 different concentrations.
Isolation and analysis of 20-fucosyllactose
For further analysis, 20-fucosyllactose was isolated from
50 ml of the fed-batch fermentation broth by activated
charcoal chromatography and gel-filtration. For cell lysis,
a 50 ml sample of fermentation broth was incubated at
100°C for 20 minutes. After subsequent centrifugation,
supernatant was applied to a column (26 × 300 mm)
filled with equal weight proportions of activated charcoal
(Merck, Germany) and Celite 545 (Fluka, Germany).
The column was washed with 2 column volumes of
water and 20-fucosyllactose was eluted by an ethanol gra-
dient. Fractions containing 20-fucosyllactose were pooled
and further purified on a gel-filtration column (26 ×
1000 mm) containing Bio-Gel P-2 (Bio-Rad, Germany).
The purified 20-fucosyllactose was analyzed by mass
spectrometry and nuclear magnetic resonance spectros-
copy. The mass was determined using a Bruker
microTOF-Q system (Bruker, Germany) with electron
spray ionization and the NMR spectra were recorded at
296 K using a Bruker Avance 500 spectrometer (Bruker,
Germany).Additional files
Additional file 1: Table S1. Primer list.
Additional file 2: Figure S1. 1H-NMR of isolated 20-fucosyllactose.
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